S&P 500   3,217.49 (+0.62%)
DOW   26,750.47 (+0.40%)
QQQ   260.47 (+0.03%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
S&P 500   3,217.49 (+0.62%)
DOW   26,750.47 (+0.40%)
QQQ   260.47 (+0.03%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
S&P 500   3,217.49 (+0.62%)
DOW   26,750.47 (+0.40%)
QQQ   260.47 (+0.03%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
S&P 500   3,217.49 (+0.62%)
DOW   26,750.47 (+0.40%)
QQQ   260.47 (+0.03%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
Log in

NYSE:CCChemours Stock Price, Forecast & News

$16.49
+0.23 (+1.41 %)
(As of 07/15/2020 02:10 PM ET)
Add
Compare
Today's Range
$16.24
Now: $16.49
$16.88
50-Day Range
$12.45
MA: $15.25
$17.65
52-Week Range
$7.02
Now: $16.49
$20.73
Volume816,518 shs
Average Volume2.96 million shs
Market Capitalization$2.71 billion
P/E RatioN/A
Dividend Yield6.42%
Beta2.44
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging. The Fluoroproducts segment provides fluoroproducts, including refrigerants, and industrial fluoropolymer resins and derivatives under the Teflon, Viton, Krytox, and Nafion brand names. The Chemical Solutions segment offers industrial and specialty chemicals for gold production, oil and gas, water treatment, electronics, and automotive industries. It also provides sodium cyanide through its mining solutions business; and performance chemicals and intermediates, such as methylamines, glycolic acid, and Vazo free radical initiators. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
Read More
Chemours logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.1Community Rank: 2.3Dividend Strength: 3.3Insider Behavior: 4.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.39 out of 5 stars


Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustryN/A
CUSIPN/A
Phone302-773-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.53 billion
Cash Flow$4.71 per share
Book Value$4.25 per share

Profitability

Net Income$-52,000,000.00

Miscellaneous

Employees7,000
Market Cap$2.71 billion
Next Earnings Date7/30/2020 (Confirmed)
OptionableOptionable

Receive CC News and Ratings via Email

Sign-up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.

Chemours (NYSE:CC) Frequently Asked Questions

How has Chemours' stock been impacted by COVID-19 (Coronavirus)?

Chemours' stock was trading at $10.66 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CC stock has increased by 54.7% and is now trading at $16.49. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Chemours?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 9 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Chemours.

When is Chemours' next earnings date?

Chemours is scheduled to release its next quarterly earnings announcement on Thursday, July 30th 2020. View our earnings forecast for Chemours.

How can I listen to Chemours' earnings call?

Chemours will be holding an earnings conference call on Thursday, July 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Chemours' earnings last quarter?

Chemours Co (NYSE:CC) issued its quarterly earnings data on Tuesday, May, 5th. The specialty chemicals company reported $0.71 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.46 by $0.25. The specialty chemicals company had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.33 billion. Chemours had a negative net margin of 0.82% and a positive return on equity of 56.54%. The company's quarterly revenue was down 5.2% on a year-over-year basis. During the same quarter last year, the business earned $0.63 EPS. View Chemours' earnings history.

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours declared a quarterly dividend on Tuesday, April 28th. Investors of record on Friday, May 15th will be given a dividend of $0.25 per share on Monday, June 15th. This represents a $1.00 annualized dividend and a dividend yield of 6.06%. The ex-dividend date of this dividend is Thursday, May 14th. View Chemours' dividend history.

What price target have analysts set for CC?

11 brokers have issued 1-year price targets for Chemours' stock. Their forecasts range from $8.00 to $21.00. On average, they anticipate Chemours' stock price to reach $14.00 in the next year. This suggests that the stock has a possible downside of 15.1%. View analysts' price targets for Chemours.

Has Chemours been receiving favorable news coverage?

Press coverage about CC stock has trended extremely negative on Wednesday, according to InfoTrie. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Chemours earned a coverage optimism score of -4.0 on InfoTrie's scale. They also assigned news stories about the specialty chemicals company a news buzz of 3.0 out of 10, indicating that recent news coverage is unlikely to have an impact on the company's share price in the next several days. View the latest news about Chemours.

Who are some of Chemours' key competitors?

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include E I Du Pont De Nemours And Co (DD), AT&T (T), NVIDIA (NVDA), Micron Technology (MU), Pfizer (PFE), Cisco Systems (CSCO), Intel (INTC), AbbVie (ABBV), Alibaba Group (BABA) and Energy Transfer LP Unit (ET).

Who are Chemours' key executives?

Chemours' management team includes the following people:
  • Mr. Mark P. Vergnano, Pres, CEO & Director (Age 61)
  • Mr. Mark E. Newman, Sr. VP & CFO (Age 56)
  • Mr. David C. Shelton Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 55)
  • Mr. E. Bryan Snell, Pres of Titanium Technologies (Age 62)
  • Mr. Paul Kirsch, Pres of Fluoroproducts Bus. (Age 55)

What is Chemours' stock symbol?

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

Who are Chemours' major shareholders?

Chemours' stock is owned by a variety of institutional and retail investors. Top institutional investors include DNB Asset Management AS (0.53%), Louisiana State Employees Retirement System (0.02%), Envestnet Asset Management Inc. (0.01%), Fruth Investment Management (0.01%) and Patriot Financial Group Insurance Agency LLC (0.00%). Company insiders that own Chemours stock include Amy Trojanowski, Bradley J Bell, David C Shelton, E Bryan Snell, Mark Newman, Mark P Vergnano, Mary B Cranston, Paul Kirsch, Richard H Brown and Susan M Kelliher. View institutional ownership trends for Chemours.

Which major investors are selling Chemours stock?

CC stock was sold by a variety of institutional investors in the last quarter, including DNB Asset Management AS, and Envestnet Asset Management Inc.. View insider buying and selling activity for Chemours.

Which major investors are buying Chemours stock?

CC stock was purchased by a variety of institutional investors in the last quarter, including Fruth Investment Management, Louisiana State Employees Retirement System, and Patriot Financial Group Insurance Agency LLC. Company insiders that have bought Chemours stock in the last two years include Bradley J Bell, David C Shelton, E Bryan Snell, Mark Newman, Mark P Vergnano, Mary B Cranston, Richard H Brown, and Susan M Kelliher. View insider buying and selling activity for Chemours.

How do I buy shares of Chemours?

Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $16.49.

How big of a company is Chemours?

Chemours has a market capitalization of $2.71 billion and generates $5.53 billion in revenue each year. The specialty chemicals company earns $-52,000,000.00 in net income (profit) each year or $2.51 on an earnings per share basis. Chemours employs 7,000 workers across the globe.

What is Chemours' official website?

The official website for Chemours is www.chemours.com.

How can I contact Chemours?

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]

This page was last updated on 7/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.